
News|Videos|October 10, 2023
EP. 13: Re-Treatment and Scheduling with OnabotulinumtoxinA
Advertisement
Please see full
Sponsored by AbbVie US Medical Affairs
Episodes in this series

This content is intended for US/PR Healthcare Professionals.
The Medical Affairs department of AbbVie Inc. is the sole author and copyright owner of this presentation and has paid Urology Times to host this presentation. AbbVie is solely responsible for all written and oral content within this presentation. © 2023 AbbVie Inc. All rights reserved.
Newsletter
Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Ayesha Dholakia, MD, discusses firearms as leading cause of US maternal death
2
Sex toy use linked to orgasm frequency in women over 60
3
Paracetamol use in pregnancy not clearly linked to autism or ADHD
4
Major gaps found in endometriosis policies worldwide
5
















